Valuation: Illumina, Inc.

Market Cap 29.01B 25.45B 23.49B 21.71B 41.15B 2,778B 41.97B 282B 110B 1,359B 109B 107B 4,719B P/E 2026 *
40.9x
P/E 2027 * 33.7x
Enterprise Value 29.54B 25.91B 23.92B 22.1B 41.89B 2,828B 42.73B 288B 112B 1,384B 111B 108B 4,804B EV / Sales 2026 *
6.46x
EV / Sales 2027 * 5.98x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
1 week+1.98%
Current month+6.65%
1 month+18.66%
3 months+46.51%
6 months+28.59%
Current year+42.98%
1 week 184.4
Extreme 184.4
196.66
1 month 155.55
Extreme 155.55
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

167 0.0001%
06-30
Corvex Management LP
OtherCompany 0 0%
06-30Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.53%+1.98%+88.91%+1.95% 29.01B
-1.41%-0.58%+19.76%-1.25% 192B
-2.10%+3.79%-20.80%+22.73% 151B
-1.83%-1.55%-4.96%-18.66% 137B
-1.43%+3.54%-56.46%-15.40% 67.33B
-0.67%+2.33%+23.23%+2.72% 54.6B
-2.84%-0.67%-26.99%-31.10% 44.94B
-1.95%-2.37%+6.15%+39.49% 36.81B
-2.24%-3.76%+6.09%+8.46% 37.04B
-4.81%+4.00%-18.49%-3.45% 31.7B
Average -2.13%+4.67%+1.64%+0.55% 78.22B
Weighted average by Cap. -1.86%+4.20%-1.71%+0.08%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.7B 3.42B 6.48B 438B 6.61B 44.49B 17.29B 214B 17.16B 16.79B 743B 4.83B 4.23B 3.91B 3.61B 6.85B 462B 6.98B 46.98B 18.26B 226B 18.12B 17.73B 785B
Net income 723M 635M 586M 541M 1.03B 69.27B 1.05B 7.04B 2.74B 33.9B 2.72B 2.66B 118B 869M 762M 704M 650M 1.23B 83.2B 1.26B 8.46B 3.29B 40.71B 3.26B 3.19B 141B
Net Debt 522M 458M 423M 391M 740M 49.98B 755M 5.08B 1.97B 24.46B 1.96B 1.92B 84.91B -160M -140M -129M -120M -227M -15.3B -231M -1.56B -604M -7.49B -600M -587M -25.98B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
08/07/26 $187.37 -2.29% 1,013,938
07/07/26 $191.76 -1.32% 2,582,918
06/07/26 $194.33 +2.99% 2,103,315
02/07/26 $188.68 +2.60% 2,941,733
01/07/26 $183.89 +4.58% 2,140,193
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
191.76USD
Average target price
155.63USD
Spread / Average Target
-18.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock